Skip to main content

Sherman Jeffrey W's Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed Jul 2, 2021

Accession no.
0001209191-21-045065
Filed
Jul 2, 2021
Trade date
Mar 10-Jul 1, 2021
Filing delay
114 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions. Open-market sales total $5.71M. It was filed 114 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sherman Jeffrey WCIK 0001230482Officer (EVP and Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 10, 2021Ordinary SharesGGiftDisposed−66,730$0.00$014,402Direct
Mar 10, 2021Ordinary SharesGGiftAcquired+66,730$0.00$066,730Indirect
Jul 1, 2021Ordinary SharesSSaleDisposed−5,287$95.00−$502,2659,115Direct
Jul 1, 2021Ordinary SharesSSaleDisposed−54,789$95.00F3−$5,204,955128,845Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)